東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

An analysis of the Medicare prescrip...

Lucarelli, Claudio.

FindBook

Google Book

Amazon

博客來

An analysis of the Medicare prescription drug benefit.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	An analysis of the Medicare prescription drug benefit./
作者:	Lucarelli, Claudio.
面頁冊數:	83 p.
附註:	Advisers: Mark V. Pauly; Eugenio J. Miravete.
Contained By:	Dissertation Abstracts International67-07A.
標題:	Economics, Labor. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3225497
ISBN:	9780542799723

An analysis of the Medicare prescription drug benefit.
Lucarelli, Claudio.

An analysis of the Medicare prescription drug benefit. - 83 p.

Advisers: Mark V. Pauly; Eugenio J. Miravete.

Thesis (Ph.D.)--University of Pennsylvania, 2006.

8,000 and Medicare has recently experienced the largest expansion of benefits since its inception: the inclusion of prescription drug coverage tinder the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The policy debate has mainly focused on estimating the cost of implementing the new benefit, with little attention to the quantification of its impact on beneficiaries' life, expectancy, health status, and health-related behaviors. The policy came into effect in January 2006; therefore, no post-policy data are available yet. This paper develops and estimates a dynamic model of the demand for supplemental health insurance and different types of medical care, and uses the model to forecast the effects of the new Medicare benefit in a way that explicitly takes into account the policy's unique actuarial design and the dynamic features it includes. The results show that the new policy increases expenditure on prescription drugs by 24%, and has a positive effect on health status and life expectancy. There is a corresponding increase in the utilization of inpatient and outpatient care, due to the extension of life for people in poor health. The cost of extending life by a year is estimated to be between

ISBN: 9780542799723Subjects--Topical Terms:

1019135
Economics, Labor.

An analysis of the Medicare prescription drug benefit.
LDR:02501nam 2200301 a 45 001 954081
005 20110621
008 110622s2006 eng d
020 $a 9780542799723
035 $a (UMI)AAI3225497
035 $a AAI3225497
040 $a UMI $c UMI
100 1 $a Lucarelli, Claudio. $3 1277561
245 1 3 $a An analysis of the Medicare prescription drug benefit.
300 $a 83 p.
500 $a Advisers: Mark V. Pauly; Eugenio J. Miravete.
500 $a Source: Dissertation Abstracts International, Volume: 67-07, Section: A, page: 2691.
502 $a Thesis (Ph.D.)--University of Pennsylvania, 2006.
520 $a Medicare has recently experienced the largest expansion of benefits since its inception: the inclusion of prescription drug coverage tinder the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The policy debate has mainly focused on estimating the cost of implementing the new benefit, with little attention to the quantification of its impact on beneficiaries' life, expectancy, health status, and health-related behaviors. The policy came into effect in January 2006; therefore, no post-policy data are available yet. This paper develops and estimates a dynamic model of the demand for supplemental health insurance and different types of medical care, and uses the model to forecast the effects of the new Medicare benefit in a way that explicitly takes into account the policy's unique actuarial design and the dynamic features it includes. The results show that the new policy increases expenditure on prescription drugs by 24%, and has a positive effect on health status and life expectancy. There is a corresponding increase in the utilization of inpatient and outpatient care, due to the extension of life for people in poor health. The cost of extending life by a year is estimated to be between $3 8,000 and $6 2,000. The take-up rate of the new benefit reaches 85% by the fifth year of implementation, and there is a sizable crowding-out effect of private plans offering supplemental prescription drug coverage. The dynamic model is also used to evaluate the impact of alternative designs for the prescription drug benefit.
590 $a School code: 0175.
650 4 $a Economics, Labor. $3 1019135
650 4 $a Health Sciences, Health Care Management. $3 1017922
650 4 $a Sociology, Public and Social Welfare. $3 1017909
690 $a 0510
690 $a 0630
690 $a 0769
710 2 $a University of Pennsylvania. $3 1017401
773 0 $t Dissertation Abstracts International $g 67-07A.
790 $a 0175
790 1 0 $a Miravete, Eugenio J., $e advisor
790 1 0 $a Pauly, Mark V., $e advisor
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3225497